Chapter 2.3 Behavioral consequences of altered corticotropin-releasing factor activation in brain: a functionalist view of affective neuroscience

Techniques in the Behavioral and Neural Sciences

Volumn 15, Issue PART 1, 2005, Pages 155-177

  Heinrichs, Stephen C ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956702348     PISSN: 09210709     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0921-0709(05)80012-4     Document Type: Chapter

References (141)

1. (Suppl.). Abbott C.R., Edwards C.M.B., Sunter D., Kim M., Dakin C.L., Murphy K.G., Abusnana S., Taheri S., Rossi M., and Bloom S.R. Cocaine- and amphetamine-regulated transcript (CART), Glucagon-like peptide-1 (GLP-1) and corticotrophin releasing factor (CRF) Reduce feeding via melanocortin 3 and 4 receptor independent pathways. Journal of Endocrinology 164 (2000) 183
2. Adinoff B., Anton R., Linnoila M., Guidotti A., Nemeroff C.B., and Bissette G. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and Diazepambinding inhibitor (DBI) during alcohol withdrawal and abstinence. Neuropsychopharmacology 15 3 (1996) 288-295
3. Akwa Y., Purdy R.H., Koob G.F., and Britton K.T. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behavioural Brain Research 106 1-2 (1999) 119-125
4. Arborelius L., Skelton K.H., Thrivikraman K.V., Plotsky P.M., Schulz D.W., and Owens M.J. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. JPET 294 2 (2000) 588-597
5. 2 Part 1. Asakawa A., Inui A., Iwamoto M., Yonenaga C., Yuzuriha H., Nagata T., Kaga T., Ueno N., and Kasuga M. Intraperitoneal injection of urocortin markedly reduces food intake and body weight and is closely related to gastric emptying in lean and ob/ob mice. Gastroenterology 114 4 Suppl (2000) A69
6. Bakshi V.P., and Kalin N.H. Corticotropin-releasing hormone and animal models of anxiety: Geneenvironment interactions. Biological Psychiatry 48 (2000) 1175-1198
7. Bakshi V.P., Smith-Roe S., Yang L.W., and Kalin N.H. Antagonism of CRF receptors within the lateral septum decreases stress-induced behavioral inhibition in rats. Society for Neuroscience Abstracts 25 1-2 (1999) 62
8. Baldwin H.A., Rassnick S., Rivier J., Koob G.F., and Britton K.T. CRF Antagonist reverses the "Anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology 103 (1991) 227-232
9. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., and Lee K.-F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nature Genetics 24 4 (2000) 410-414
10. Baram T.Z., Mitchell W.G., Brunson K., and Haden E. Infantile spasms: Hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone receptor antagonists. Developmental Neuroscience 21 3-5 (1999) 281-289
11. Basso A.M., Spina M., Rivier J., Vale W., and Koob G.F. Corticotropin-releasing factor antagonist attenuates the "Anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology 145 1 (1999) 21-30
12. Beck B., Burlet A., Nicolas J.-P., and Burlet C. Hypothalamic neuropeptide Y (NPY) in obese zucker rats: implications in feeding and sexual behaviors. Physiol. Behav. 47 (1990) 449-453
13. Behan D.P., De Souza E.B., Lowry P.J., Potter E., Sawchenko P., and Vale W.W. Corticotropin releasing factor (CRF) binding protein: A novel regulator of CRF and related peptides. Frontiers in Neuroendocrinology 16 (1995) 362-382
14. Behan D.P., Heinrichs S.C., Troncoso J.C., Liu X.J., Kawas C.H., Ling N., and De Souza E.B. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 378 6554 (1995) 284-287
15. Behan D.P., Potter E., Lewis K.A., Jenkins N.A., Copeland N., Lowry P.J., and Vale W. Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP). Genomics 16 (1993) 63-68
16. Bell S.M., Reynolds J.G., Thiele T.E., Gan J., Figlewicz D.P., and Woods S.C. Effects of third intracerebroventricular injections of corticotropin-releasing factor (CRF) on ethanol drinking and food intake. Psychopharm. 139 (1998) 128-135
17. Benoit S.C., Thiele T.E., Heinrichs S.C., Rushing P.A., Blake K.A., and Seeley R.J. Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression. Peptides 21 3 (2000) 345-351
18. Berridge K.C. Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci. Biobehav. Rev. 24 2 (2000) 173-198
19. Berridge C.W., and Dunn A.J. Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice. Regulatory Peptides 16 (1986) 83-93
20. Bjenning C.A., and Rimvall K. CRF and CRF (6-33) depress food but not water intake in the obese Zucker rat. International Journal of Obesity 24 Suppl. 2 (2000) S140-S141
21. Blank T., Nijholt I., Eckart K., and Spiess J. Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J. Neurosci. 22 9 (2002) 3788-3794
22. Blank T., Nijholt I., Grammatopoulos D.K., Randeva H.S., Hillhouse E.W., and Spiess J. Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J Neurosci. 23 2 (2003) 700-707
23. Blank T., Nijholt I., Vollstaedt S., and Spiess J. The corticotropin-releasing factor receptor 1 antagonist CP-154,526 reverses stress-induced learning deficits in mice. Behav. Brain. Res. 138 2 (2003) 207-213
24. Bonaz B., and Rivest S. Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. American Journal of Physiology 275 5 PART 2 (1998) R1438-R1449
25. Born J., Spath-Schwalbe E., Schwakenhofer H., Kern W., and Fehm H.L. Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. Journal of Clinical Endocrinology and Metabolism 68 5 (1989) 904-911
26. Bradley M.M., and Lang P.J. Measuring emotion: behavior, feeling, and physiology. In: Lane R.D., and Nadel L. (Eds). Cognitive Neuroscience of Emotion (2000), Oxford University Press, Amsterdam
27. Brady L.S., Smith M.A., Gold P.W., and Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52 (1990) 441-447
28. Britton D.R., Koob G.F., Rivier J., and Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 31 (1982) 363-367
29. Britton K.T., Lee G., Vale W., Rivier J., and Koob G.F. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res. 369 1-2 (1986) 303-306
30. Brunani A., Invitti C., Dubini A., Piccoletti R., Bendinelli P., Maroni P., Pezzoli G., Ramella G., Calogero A., and Cavagnini F. Cerebrospinal gluid and plasma concentrations of SRIH, beta-endorphin, CRF, NPY and GHRH in obese and normal weight subjects. International Journal of Obesity 19 (1995) 17-21
31. Brunson K.L., Eghbal-Ahmadi M., and Baram T.Z. How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis. Brain & Development 23 7 (2001) 533-538
32. Buck R. The Biological Affects: A typology. Psychological Review 106 2 (1999) 301-336
33. Buwalda B., de Boer S.F., Van Kalkeren A.A., and Koolhaas J.M. Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology 22 5 (1997) 297-309
34. Cador M., Cole B.J., Koob G.F., Stinus L., and Le M.M. Central administration of CRF produces sensitization of amphetamine-induced behavior. Soc. Neurosci. Abstr. 15 252 (1989) 252
35. Chang F.-C., and Opp M.R. Pituitary CRH receptor blockade reduces waking in the rat. Physiol. Behav. 67 5 (1999) 691-696
36. Chang F.C., and Opp M.R. Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 2 (2002) R400-R407
37. Chen Y.L., Braselton J., Collins J., Costello D., Corman M., Dunaiskis A., Faraci S., Heym J., Mansbach R., Schmidt A., Schulz D., Seeger T., Sprouse J., Tingley D., and Winston E. CP-154-526: A potent and selective non-peptide. 212 ACS National Meeting (1996), American Chemical Society, Orlando FL
38. Chen Y.L., Mansbach R.S., Winter S.M., Brooks E., Collins J., Corman M.L., Dunaiskis A.R., Faraci W.S., Gallaschun R.J., Schmidt A., and Schulz D.W. Synthesis and oral efficacy of a 4-(Butylethylamino)pyrrolo [2,3-d]pyrimidine: a centrally active corticotropin-releasing factor 1 receptor antagonist. Journal of Medicinal Chemistry 40 11 (1997) 1749-1752
39. Cizza G., Gold P.W., and Chrousos G.P. Aging is associated in the 344/N Fischer rat with decreased stress responsivity of central and peripheral catecholaminergic systems and impairment of the hypothalamic-pituitary-adrenal Axis. Ann. N. Y. Acad. Sci. 771 (1995) 491-511
40. Cole B.J., Britton K.T., and Koob G.F. Central administration of alpha-helical corticotropin-releasing factor attenuates the acquisition of a conditioned emotional response. Neuroscience Abstracts 13 (1987) 427
41. Cole B.J., Cador M., Stinus L., Rivier C., Rivier J., Vale W., LeMoal M., and Koob G.F. Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. Life Sci. 47 (1990) 1715-1720
42. Cole B.J., Cador M., Stinus L., Rivier J., Vale W., and Koob G.F. Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res. 512 (1990) 343-346
43. Contarino A., Dellu F., Koob G.F., and Gold L.H. Reduced anxiety-like and cognitive performance in mice. lacking the corticotropin-releasing factor receptor 1. Brain Res. 835 (1999) 1-9
44. Contarino A., Heinrichs S.C., and Gold L.H. Understanding CRF neurobiology: contribution from mutant mice. Neuropeptides 33 (1999) 1-12
45. Crawley J.N. What's wrong with my mouse?. Behavioral phenotyping of trangenic and knockout mice (2000), Wiley-Liss
46. Dagnault A., Ouerghi D., and Richard D. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol. Brain Research Bulletin 32 6 (1993) 689-692
47. De Souza E., Whitehouse P.J., Kuhar M.J., Price D.L., and Vale W. Reciprocal changes in corticotropin-releasing factor (CRF)-like Alzheimer's disease. Nature 319 593 (1986) 593-595
48. Dirks A., Groenink L., Schipholt M.I., van der Gugten J., Hijzen T.H., Geyer M.A., and Olivier B. Reduced startle reactivity and plasticity in transgenic mice over-expressing corticotropin-releasing hormone. Biol. Psychiatry 51 7 (2002) 583-590
49. Dryden S., McCarthy H.D., Malabu U.H., Ware M., and Williams G. Increased neuropeptide Y concentrations in specific hypothalamic nuclei of the rat following treatment with methysergide: evidence that NPY may mediate serotonin's effects on food intake. Peptides 14 (1993) 791-796
50. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety of stress responses?. Brain Research Reviews 15 (1990) 71-100
51. Eaves M., Thatcher B.K., Rivier J., Vale W., and Koob G.F. Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats. Peptides 6 5 (1985) 923-926
52. Eckart K., Radulovic J., Radulovic M., Jahn O., Blank T., Stiedl O., and Spiess J. Actions of CRF and its analogs. Curr. Med. Chem. 6 11 (1999) 1035-1053
53. Ehlers C.L., Henriksen S.J., Wang M., Rivier J., Vale W., and Bloom F.E. Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in the rat. Brain Res. 278 332 (1983) 332-336
54. Ehlers C.L., Reed T.K., and Henriksen S.J. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 42 6 (1986) 467-474
55. Erb S., Hitchcott P.K., Rajabi H., Mueller D., Shaham Y., and Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23 2 (2000) 138-150
56. Erb S., Shaham Y., and Stewart J. The role of corticotropin-releasing factor and corticosterone in stress-and cocaine-induced relapse to cocaine seeking in rats. J. Neurosci. 14 (1998) 5529-5536
57. Fuchs E., Flügge G., Ohl F., Lucassen P., Vollmann-Honsdorf G.K., and Michaelis T.M. Psychosocial stress, glucocorticoids, and the structural alterations in the tree shrew hippocampus. Physiol. Behav. 73 (2001) 285-291
58. Glowa J.R., Barrett J.E., Russell J., and Gold P.W. Effects of corticotropin releasing hormone on appetitive behaviors. Peptides 13 (1992) 609-621
59. Goeders N.E., and Guerin G.F. Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats. Neuropsychopharmacology 23 5 (2000) 577-586
60. Gray T.S. Amygdaloid CRF Pathways: Role in autonomic, neuroendocrine, and behavioral responses to stress. Annals of the New York Academy of Sciences 697 (1993) 53-60
61. Griebel G., Perrault G., and Sanger D.J. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Psychopharmacology 138 1 (1998) 55-66
62. Groenink L., Dirks A., Verdouw P.M., Schipholt M., Veening J.G., van der Gugten J., and Olivier B. HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biol. Psychiatry 51 11 (2002) 875-881
63. Groenink L., Pattij T., De Jongh R., Van der Gugten J., Oosting R.S., Dirks A., and Olivier B. 5-HT(1A) Receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. Eur. J. Pharmacol. 463 1-3 (2003) 185-197
64. Grossman A., Costa A., Navarra P., and Tsagarakis S. The regulation of hypothalamic corticotropin-releasing factor release: in vitro studies. In: Chadwick D.J., Marsh J., and Ackrill K. (Eds). Corticotropin-releasing Factor (1993), Wiley, New York 129-150
65. Habib K.E., Rice K.C., Chrousos G.P., and Gold P.W. CRH-1 Receptor antagonism exerts antidepressant-and anxiolytic-like effects in attenuating stress ulcerogenesis. FASEB Journal 14 4 (2000) A338
66. Hartline K.M., Owens M.J., and Nemeroff C.B. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans. Annals of the New York Academy of Sciences 780 (1996) 96-105
67. Heinrichs S.C., Britton K.T., and Koob G.F. Both conditioned taste preference and aversion induced by corticotropin-releasing factor. Pharmacol. Biochem. Behav. 40 4 (1991) 717-721
68. Heinrichs S.C., and De Souza E.B. Corticotropin-releasing factor in brain: executive gating of neuroendocrine and functional outflow. In: McEwen B.S. (Ed). Handbook of Physiology. Volume 7: Coping with the Environment: Neural and Endocrine Mechanisms (2001), Oxford University Press, Chichester 125-137
69. Heinrichs S.C., De Souza E.B., Schulteis G., Lapsansky J.L., and Grigoriadis D.E. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist. Neuropsychopharmacology 27 2 (2002) 194-202
70. Heinrichs S.C., and Joppa M. Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats. Behav. Brain Res. 122 1 (2001) 43-50
71. Heinrichs S.C., Lapsansky J., Lovenberg T.W., De Souza E.B., and Chalmers D.T. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regulatory Peptides 71 (1997) 15-21
72. Heinrichs S.C., Li D.L., Katner J., and Ivengar S. Effects of corticotropin-releasing factor (CRF) and the CRF binding-protein ligand inhibitor, CRF(6-33), on acute food intake and body temperature in rodents. Society for Neuroscience Abstracts 25 1-2 (1999) 1119
73. Heinrichs S.C., Menzaghi F., Merlo Pich E., Baldwin H.A., Rassnick S., Britton K.T., and Koob G.F. Antistress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology 11 3 (1994) 179-186
74. Heinrichs S.C., and Richard D. The role of corticotropin-releasing factor and urocortion in the modulation of ingestive behavior. Neuropeptides 33 5 (1999) 350-359
75. Heinrichs S.C., Stenzel-Poore M.P., Gold L.H., Battenberg E., Bloom F.E., Koob G.F., Vale W.W., and Merlo Pich E. Learning deficits in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience 74 2 (1996) 303-311
76. Heinrichs S.C., Vale E.A., Lapsansky J., Behan D.P., McClure L.V., Ling N., De Souza E.B., and Schulteis G. Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. Peptides 18 5 (1997) 711-716
77. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. Journal of Psychiatric Research 33 3 (1999) 181-214
78. Holt S., Ford M.J., Grant S., and Heading R.C. Abnormal gastric emptying in primary anorexia nervosa. British Journal of Psychiatry 139 (1981) 550-552
79. Hotta M., Shabasaki T., Arai K., and Demura H. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Research 823 (1999) 221-225
80. Ida T., Nakahara K., Kuroiwa T., Fukui K., Nakazato M., Murakami T., and Murakami N. Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neuroscience Letters 293 2 (2000) 119-122
81. Inui A., Okano H., Miyamoto M., Aoyama N., Uemoto M., Baba S., and Kasuga M. Delayed gastric emptying in bulimic patients. Lancet 436 (1995) 1240
82. Iredale P.A., Alvaro J.D., Lee Y., Terwilliger R., Chen Y.L., and Duman R.S. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. Journal of Neurochemistry 74 1 (2000) 199-208
83. Jeanrenaud B. Central nervous system and peripheral abnormalities: clues to the understanding of obesity and NIDDM. Diabetologia 37 Suppl. 2 (1994) S169-S178
84. Jones D.N.C., Kortekaas R., Hatcher P.D., Middlemiss D.N., White A., and Hagan J.J. Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF. European Journal of Pharmacology 373 2-3 (1999) 141-145
85. Koob G.F. Corticotropin-releasing Factor, norepinephrine, and stress. Biological Psychiatry 46 9 (1999) 1167-1180
86. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 2 (2001) 97-129
87. Korte S.M., Korte-Bouws G.A.H., Gohus B., and Koob G.F. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats. Physiology & Behavior 56 (1994) 115-120
88. Krahn D.D., and Gosnell B.A. Corticotropin-releasing hormone: possible role in eating disorders. Psychiatric Medicine 7 (1989) 235-245
89. Lancel M., Muller-Preuss P., Wigger A., Landgraf R., and Holsboer F. The CRH1 receptor antagonist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety. J. Psychiat. Res. 36 4 (2002) 197-208
90. LeDoux J. Cognitive-emotional interactions: listen to the brain. In: Lane R.D., and Nadel L. (Eds). Cognitive Neuroscience of Emotion (2000), Oxford University Press, New York
91. Lehmann J., Stohr T., and Feldon J. Long-term effects of prenatal stress experience and postnatal matemal separation on emotionality and attentional processes. Behavioural Brain Research 107 1-2 (2000) 133-144
92. Liang K.C., Chen H.C., and Chen D.Y. Posttraining infusion of norepinephrine and corticotropin releasing factor into the bed nucleus of the stria terminalis enhanced retention in an inhibitory avoidance task. Chin. J. Physiol. 44 1 (2001) 33-43
93. Lohman T.G., Caballero B., Himes J.H., Davis C.E., Stewart D., Houtkooper L., Going S.B., Hunsberger S., Weber J.L., Reid R., and Stephenson L. Estimation of body fat from anthropometry and bioelectrical impedance in Native American children. International Journal of Obesity 24 8 (2000) 982-988
94. Lovejoy D.A., and Balment R.J. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates. General and Comparative Endocrinology 115 1 (1999) 1-22
95. Lowry P.J., Woods R.J., and Baigent S. Corticotropin releasing factor and its binding protein. Pharmacol. Biochem. Behav. 54 1 (1996) 305-308
96. Meerlo P., De Boer S.F., Koolhaas J.M., Daan S., and Van Den Hoofdakker R.H. Changes in daily rhythms of body temperature and activity after a single social defeat in rats. Physiology & Behavior 59 4/5 (1996) 735-739
97. Menzaghi F., Heinrichs S.C., Merlo Pich E., Tilders F.J.H., and Koob G.F. Functional impairment of hypothalamic corticotropin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y. Brain Research 618 (1993) 76-82
98. Menzaghi F., Howard R.L., Heinrichs S.C., Vale W., Rivier J., and Koob G.F. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. JPET 269 2 (1994) 564-572
99. Nemeroff C. Clinical studies on the role of CRF in mood and anxiety disorders. Neuropsychopharmacology 23 S2 (2000) S5
100. Ohata H., Suzuki K., Oki Y., and Shibasaki T. Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats. Brain Res. 861 1 (2000) 1-7
101. Opp M.R. Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Advances in Neuroimmunology 5 (1995) 127-143
102. Owens M.J., and Nemeroff C.B. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. In: Chadwick D.J., Marsh J., and Ackrill K. (Eds). Corticotropin-releasing Factor (1993), John Wiley and Sons, New York 296-316
103. Panksepp J. Affective Neuroscience (1998), Oxford University Press, Chichester
104. Pelleymounter M.A., Joppa M., Carmouche M., Cullen M.J., Brown B., Murphy B., Grigoriadis D.E., Ling N., and Foster A.C. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. JPET 293 3 (2000) 799-806
105. Piazza P.V., and Le Moal M. Pathophysiological basis of vulnerability to drug abuse: interaction between stress, glucocorticoids, and dopaminergic neurons. Ann. Rev. Pharmacol. Toxicol 36 (1996) 359-378
106. Plotsky P.M., Cunningham E.T., and Widmaier E.P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrinological Reviews 10 (1989) 437-458
107. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., and Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proceedings of the National Academy of Sciences (USA) 89 (1992) 4192-4196
108. Radulovic J., Fischer A., Katerkamp U., and Spiess J. Role of regional neurotransmitter receptors in corticotropin-releasing factor (CRF)-mediated modulation of fear conditioning. Neuropharmacology 39 4 (2000) 707-710
109. Rebaudo R., Melani R., Balestrino M., and Izvarina N. Electrophysiological effects of sustained delivery of CRF and its receptor agonists in hippocampal slices. Brain Res 922 1 (2001) 112-117
110. Richter R.M., Merlo Pich E., Koob G.F., and Weiss F. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neuroscience Letters 187 (1995) 169-172
111. Rolls E.T. The Brain and Emotion (1999), Oxford University Press, New York
112. Rothwell N.J. Central effects of CRF on metabolism and energy balance. Neuroscience and Biobehavioral Reviews 14 (1990) 263-271
113. Russell J.A. Core affect and the psychological construction of emotion. Psychological Review 110 1 (2003) 145-172
114. Sarnyai Z., Höhn J., Szabó G., and Penke B. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. Life Sciences 51 (1992) 2019-2024
115. Sarnyai Z., Shaham Y., and Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacological Reviews 53 2 (2001) 209-243
116. Schulz D.W., Mansbach R.S., Sprouse J., Braselton J.P., Collins J., Dunaiskis C.M.A., Faraci S., Schmidt A.W., Seeger T., Seymour P., Tingley III F.D., Winston E.N., Chen Y.L., and Heym J. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proceedings of the National Academy of Sciences (USA) 93 (1996) 10477-10482
117. Selye H. The Stress of Life (1976), McGraw-Hill, Oxford
118. Slawecki C.J., Somes C., Rivier J.E., and Ehlers C.L. Neurophysiological effects of intracerebroventricular administration of urocortin. Peptides (New York) 20 2 (1999) 211-218
119. Smith G.W., Aubry J.-M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., and Lee K.-F. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20 (1998) 1093-1102
120. Smith M.A., Weiss S.R.B., Berry R.L., Zhang L.-X., Clark M., Massenburg G., and Post R.M. Amygdala-kindled seizures increase the expression of corticotropin-releasing factor (CRF) and CRF-binding protein in GABAergic interneurons of the dentate hilus. Brain Res. 745 (1997) 248-256
121. Spina M.G., Basso A.M., Zorrilla E.P., Heyser C.J., Rivier J., Vale W., Merlo-Pich E., and Koob G.F. Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology 22 3 (2000) 230-239
122. Steckler T., and Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biological Psychiatry 46 11 (1999) 1480-1508
123. Stratakis C.A., and Chrousos G.P. Neuroendocrinology and pathophysiology of the stress system. Annals of the New York Academy of Sciences 771 (1995) 1-18
124. Sutton R.E., Koob G.F., Le Moal M., Rivier J., and Vale W. Corticotropin-releasing factor (CRF) produces behavioral activation in rats. Nature 297 (1982) 331-333
125. Swerdlow N.R., Britton K.T., and Koob G.F. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by a-helical CRF (9-41). Neuropsychopharmacology 2 (1989) 285-292
126. Swerdlow N.R., and Koob G.F. Separate neural substrates of the locomotor-activating properties of amphetamine, caffeine and corticotropin releasing factor (CRF) in the rat. Pharmacology Biochemistry and Behavior 23 (1985) 303-307
127. Taché Y., Martinez V., Million M., and Rivier J. Corticotropin-releasing factor and the brain-gut motor response to stress. Canadian Journal of Gastroenterology 13 Suppl. A (1999) 18A-25A
128. Takahashi L.K., Kalin N.H., Vandenburgt J.A., and Sherman J.E. Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behavioral Neuroscience 103 (1989) 648-654
129. Timpl P., Spanagel R., Sillaber I., Kress A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., and Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nature Genetics 19 2 (1998) 162-166
130. Turnbull A.V., and Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proceedings of the Society for Experimental Biology and Medicine 215 (1997) 1-10
131. Valentino R.J., Foote S.L., and Page M.E. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Annals of the New York Academy of Sciences 697 (1993) 173-188
132. van Gaalen M.M., Stenzel-Poore M., Holsboer F., and Steckler T. Reduced attention in mice overproducing corticotropin-releasing hormone. Behav. Brain Res. 142 1-2 (2003) 69-79
133. Vargas M.A., Bissette G., Owens M.J., Ehlers C.L., and Nemeroff C.B. Effects of chronic ethanol and benzodiazepine treatment and withdrawal on corticotropin-releasing factor neural systems. Annals of the New York Academy of Sciences 654 (1992) 145-152
134. Wang H.L., Wayner M.J., Chai C.Y., and Lee E.H. Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur. J. Neurosci. 10 11 (1998) 3428-3437
135. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P., Valdez G.R., Ben-Shahar O., Angeletti S., and Richter R.R. Compulsive Drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann. N. Y. Acad. Sci. 937 (2001) 1-26
136. Weninger S.C., Dunn A.J., Muglia L.J., Dikkes P., Miczek K.A., Swiergiel A.H., Berridge C.W., and Majzoub J.A. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 8283-8288 14
137. Weninger S.C., Muglia L.J., Jacobson L., and Majzoub J.A. CRH-deficient mice have a normal anorectic response to chronic stress. Regulatory Peptides 84 1-3 (1999) 69-74
138. Widmaier E.P. Changes in responsiveness of the hypothalamic-pituitary-adrenal axis to 2-deoxy-d-glucose in developing rats. Endocrinology 126 6 (1990) 3116-3123
139. Wiederman M.W., and Pryor T.L. Body dissatisfaction, bulimia, and depression among women: the mediating role of drive for thinness. Int. J. Eat., Dis. 27 1 (2000) 90-95
140. Yamano M., Yuki H., Yasuda S., and Miyata K. Corticotropin-releasing hormone1 receptors mediate consensus interferon-a YM643-induced depression-like behavior in mice. JPET 292 (2000) 181-187
141. Zorrilla E.P., Schulteis G., Ling N., Koob G.F., and De Souza E.B. Performance-enhancing effects of CRF-BP ligand inhibitors. Neuroreport 12 6 (2001) 1231-1234